These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11501986)

  • 1. Antifungal resistance among Candida species.
    Klepser ME
    Pharmacotherapy; 2001 Aug; 21(8 Pt 2):124S-132S. PubMed ID: 11501986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro resistance of Candida species to antifungal agents].
    Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
    Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
    Defontaine A; Bouchara JP; Declerk P; Planchenault C; Chabasse D; Hallet JN
    J Med Microbiol; 1999 Jul; 48(7):663-670. PubMed ID: 10403417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal drug resistance to azoles and polyenes.
    Masiá Canuto M; Gutiérrez Rodero F
    Lancet Infect Dis; 2002 Sep; 2(9):550-63. PubMed ID: 12206971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to antifungal drugs.
    Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antifungals for systemic use].
    Ruiz-Camps I; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of mechanisms of antifungal drug resistance in yeasts.
    Sanglard D
    Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):462-9; quiz 470, 479. PubMed ID: 12425880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
    Gonçalves SS; Amorim CS; Nucci M; Padovan AC; Briones MR; Melo AS; Colombo AL
    Clin Microbiol Infect; 2010 Jul; 16(7):885-7. PubMed ID: 19686280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.
    Cross EW; Park S; Perlin DS
    Microb Drug Resist; 2000; 6(2):155-61. PubMed ID: 10990271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal drug resistance among Candida species: mechanisms and clinical impact.
    Sanguinetti M; Posteraro B; Lass-Flörl C
    Mycoses; 2015 Jun; 58 Suppl 2():2-13. PubMed ID: 26033251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antifungal resistance development on the virulence of Candida species.
    Bohner F; Papp C; Gácser A
    FEMS Yeast Res; 2022 Apr; 22(1):. PubMed ID: 35325128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole susceptibility and resistance in Candida dubliniensis.
    Pinjon E; Moran GP; Coleman DC; Sullivan DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal resistance in Aspergillus.
    Chandrasekar PH
    Med Mycol; 2005 May; 43 Suppl 1():S295-8. PubMed ID: 16110823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.
    Wingard JR
    Clin Infect Dis; 1994 Aug; 19 Suppl 1():S49-53. PubMed ID: 7948571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.
    Jensen RH; Johansen HK; Søes LM; Lemming LE; Rosenvinge FS; Nielsen L; Olesen B; Kristensen L; Dzajic E; Astvad KM; Arendrup MC
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1500-8. PubMed ID: 26711776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent approaches to antifungal therapy for invasive mycoses.
    Mathew BP; Nath M
    ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungals in Clinical Use and the Pipeline.
    Johnson MD
    Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.
    Fakhim H; Emami S; Vaezi A; Hashemi SM; Faeli L; Diba K; Dannaoui E; Badali H
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activities of diphenyl diselenide and ebselen against echinocandin-susceptible and -resistant strains of Candida parapsilosis.
    Chassot F; Pozzebon Venturini T; Baldissera Piasentin F; Morais Santurio J; Estivalet Svidzinski TI; Hartz Alves S
    New Microbiol; 2016 Oct; 39(4):301-303. PubMed ID: 27727401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review.
    Mishra NN; Prasad T; Sharma N; Payasi A; Prasad R; Gupta DK; Singh R
    Acta Microbiol Immunol Hung; 2007 Sep; 54(3):201-35. PubMed ID: 17896473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.